CIK 0001287098
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
MAXCYTE, INC.
Sign in to watch- Ticker
- MXCT
- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 522210438
- Phone
- +1 301-517-5556
- Business address
- 9713 KEY WEST AVENUE,, SUITE 400, ROCKVILLE, MD, 20850
- Former names
- MAXCYTE INC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale 10% owner sold 3,235,548 shares at $4.30 ($13,912,856)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 20,000 shares at $11.12 ($222,400)
- 4 Open-market sale EVP and General Counsel sold 75,000 shares at an average $12.31 ($923,376)
- 4 Open-market sale Chief Financial Officer sold 150,000 shares at an average $12.31 ($1,846,567)
- 4 Open-market sale EVP, Global Sales sold 125,105 shares at an average $12.31 ($1,540,079)
- 4 Open-market sale SVP and CAO sold 150,000 shares at an average $12.29 ($1,843,647)
- 4 Open-market sale President and CEO sold 300,000 shares at an average $12.31 ($3,692,932)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 7 of 9 · 163 filings